The Gut Punch Weekly #1GLP-1s will disrupt the economy in 2025, FDA declares the tirzepatide shortage over, Novo Nordisk stock plummets, and much more.Lance LivelyJan 01, 2025∙ Paid2ShareContinue reading this post for free, courtesy of Lance Lively.Claim my free postOr purchase a paid subscription.Next
